Physician

Manuel Alejandro Gonzalez, MD, MPH, MBA

According to 2025 Medicare claims, Manuel Gonzalez, MD, MPH, MBA (NPI: 1639182371) practices peripheral vascular disease in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is WOUND CARE AND LIMB SALVAGE GROUP OF MIAMI PA (NPI: 1285107664; TIN: 833036771) and primary practice location at 33126-2041.

Gonzalez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 1,519 HCPCS/CPT codes, and received $2,158,638 in Medicare payments. The top billing code was 37227 (Removal of plaque and insertion of stents in arteries of leg). Part D data shows 1,707 prescription claims across 230 beneficiaries totaling $136,187 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 42 claims. Open Payments data shows 5 records totaling $109. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $5,574,484 to $2,158,638. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $37,223 to $136,187. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $818 and ending at $1,783.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	494	3,848	$5,574,484
2016	583	3,839	$5,571,120
2017	337	3,367	$3,549,125
2018	325	2,232	$3,014,885
2019	208	1,389	$2,244,052
2020	217	1,730	$2,349,249
2021	190	1,343	$1,831,594
2022	217	1,312	$1,728,895
2023	311	1,768	$2,233,470
2024	270	1,519	$2,158,638

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	155	849	$37,223
2016	453	3,242	$221,914
2017	368	2,381	$146,333
2018	206	1,095	$85,828
2019	139	688	$55,186
2020	88	379	$55,746
2021	76	327	$33,662
2022	86	435	$29,588
2023	150	1,034	$95,184
2024	230	1,707	$136,187

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	32	62	$869
2017	11	42	$410
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
37227	Removal of plaque and insertion of stents in arteries of leg	67	108	$8,172
37229	Removal of plaque in artery of leg, initial vessel	77	118	$5,100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	80	$105
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	97	196	$39
76937	Ultrasonic guidance for blood vessel access	97	196	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	205	2,979	$63,001
Xarelto	Rivaroxaban	83	1,515	$29,659
Jardiance	Empagliflozin	14	580	$11,639
Atorvastatin Calcium	Atorvastatin Calcium	292	9,353	$9,485
Clopidogrel	Clopidogrel Bisulfate	495	16,138	$7,746

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$109	Myriad Genetic Laboratories, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manuel Alejandro Gonzalez, MD, MPH, MBA?

Tedicare shows public-source Medicare data for Manuel Alejandro Gonzalez, MD, MPH, MBA (NPI 1639182371), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manuel Alejandro Gonzalez, MD, MPH, MBA have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Manuel Alejandro Gonzalez, MD, MPH, MBA?

Manuel Alejandro Gonzalez, MD, MPH, MBA is linked to WOUND CARE AND LIMB SALVAGE GROUP OF MIAMI PA (billing NPI 1285107664) in the available physician profile data.

Does Manuel Alejandro Gonzalez, MD, MPH, MBA have Open Payments data?

Manuel Alejandro Gonzalez, MD, MPH, MBA has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.